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2010-2011 Influenza Season 
Week 16 ending April 23, 2011 
All data are preliminary and may change as more reports are received. 
 
Synopsis: During week 16 (April 17-23, 2011), influenza activity in the United States continued to 
decrease.  
o Of the 2,072 specimens tested by U.S. World Health Organization (WHO) and National 
Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and 
reported to CDC/Influenza Division, 88 (4.3%) were positive for influenza. 
o The proportion of deaths attributed to pneumonia and influenza (P&I) has been at or above 
the epidemic threshold for 13 consecutive weeks. 
o Two influenza-associated pediatric deaths were reported, bringing the season total to 97. 
Both of these deaths were associated with an influenza B virus. 
o The proportion of outpatient visits for influenza-like illness (ILI) was 1.3%, which is below the 
national baseline of 2.5%. Region 2 reported ILI above its region-specific baseline. All 50 
states and New York City experienced minimal ILI activity, and the District of Columbia had 
insufficient data to calculate an ILI activity level. 
o The geographic spread of influenza in four states was reported as regional; the District of 
Columbia and 10 states reported local influenza activity; Puerto Rico and 32 states reported 
sporadic influenza activity, and the U.S. Virgin Islands, Guam, and four states reported no 
influenza activity. 
 
National and Regional Summary of Select Surveillance Components 
 Data for current week Data cumulative since October 3, 2010 (Week 40) 
HHS 
Surveillance 
Regions* 
Out-
patient 
ILI† 
% 
positive 
for flu‡ 
Number of 
jurisdictions 
reporting 
regional or 
widespread 
activity§ 
A (H3) 
2009 A 
(H1N1) 
A 
(Subtyping not 
performed) 
B 
Pediatric 
Deaths 
Nation Normal 4.3% 4 of 54 16,728 10,867 11,296 13,609 97 
Region 1 Normal 17.3% 3 of 6 1,709 912 96 448 3 
Region 2 Elevated 10.7% 1 of 4 755 365 1,111 453 11 
Region 3 Normal 9.9% 0 of 6 2,970 2,568 858 1,013 10 
Region 4 Normal 3.1% 0 of 8 1,467 1,430 3,150 3,953 16 
Region 5 Normal 21.6% 0 of 6 2,092 1,531 447 1,303 18 
Region 6 Normal 1.4% 0 of 5 2,186 562 2,306 2,565 17 
Region 7 Normal 4.4% 0 of 4 712 539 286 675 1 
Region 8 Normal 6.8% 0 of 6 1,731 687 2,118 1,876 7 
Region 9 Normal 4.8% 0 of 5 1,994 1,464 745 1,191 12 
Region 10 Normal 13.5% 0 of 4 1,112 809 179 132 2 
*HHS regions (Region 1 CT, ME, MA, NH, RI, VT; Region 2: NJ, NY, Puerto Rico, U.S. Virgin Islands; Region 3: DE, DC, MD, PA, VA, WV; Region 4: AL, FL, GA, KY, MS, NC, 
SC, TN; Region 5: IL, IN, MI, MN, OH, WI; Region 6: AR, LA, NM, OK, TX; Region 7: IA, KS, MO, NE; Region 8: CO, MT, ND, SD, UT, WY; Region 9: AZ, CA, Guam, HI, NV; 
and Region 10: AK, ID, OR, WA). 
† Elevated means the % of visits for ILI is at or above the national or region-specific baseline. 
‡ National data are for current week; regional data are for the most recent three weeks. 
§ Includes all 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands. 
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U.S. Virologic Surveillance: WHO and NREVSS collaborating laboratories located in all 50 states 
and Washington, D.C., report to CDC the number of respiratory specimens tested for influenza and 
the number positive by influenza type and subtype. The results of tests performed during the 
current week are summarized in the table below. 
 
 Week 16 
No. of specimens tested 2,072 
No. of positive specimens (%) 88 (4.3%) 
Positive specimens by type/subtype  
Influenza A 50 (56.8%) 
          A (2009 H1N1)   5 (10.0%)             
          A (subtyping not performed)          13 (26.0%) 
          A (H3)                32 (64.0%)     
Influenza B 38 (43.2%) 
 
All influenza types and subtypes were identified at high levels this season, but in recent weeks have 
circulated at much lower levels. The predominant virus has varied by week, region, and even 
between states within the same region. In recent weeks the proportion of influenza B viruses 
identified nationally and in some regions has been increasing and in week 16 five of the 10 regions 
(Regions 1, 2, 6, 7, and 8) identified at least half of all influenza-positive specimens as influenza B 
viruses. 
 
Influenza Positive Tests Reported to CDC by U.S. WHO/NREVSS 
Collaborating Laboratories, National Summary, 2010-11 Season 
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Aggregate Hospitalization and Death Reporting Activity (AHDRA): This system tracks weekly 
counts of laboratory-confirmed influenza-associated hospitalizations and deaths and was 
implemented on August 30, 2009, during the 2009 H1N1 pandemic, and ended on April 4, 2010. 
AHDRA surveillance during the 2010-11 season has continued on a voluntary basis, and 19 
jurisdictions reported during week 16. From October 3, 2010 – April 23, 2011, 16,033 laboratory-
confirmed influenza-associated hospitalizations and 311 laboratory-confirmed influenza-associated 
deaths were reported to CDC. 
  
Weekly Laboratory-Confirmed Influenza-Associated Hospitalizations and 
Deaths, National Summary, 2010-11 Season 
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Antigenic Characterization: CDC has antigenically characterized 2,088 influenza viruses [490 
2009 influenza A (H1N1) viruses, 952 influenza A (H3N2) viruses, and 646 influenza B viruses] 
collected by U.S. laboratories since October 1, 2010. 
2009 Influenza A (H1N1) [490] 
 Four hundred eighty-nine (99.8%) of the 490 tested were characterized as 
A/California/7/2009-like, the influenza A (H1N1) component of the 2010-11 influenza 
vaccine for the Northern Hemisphere. One virus (0.2%) of the 490 tested showed 
reduced titers with antiserum produced against A/California/7/2009. 
 
Influenza A (H3N2) [952] 
 Nine hundred nineteen (96.5%) of the 952 tested were characterized as 
A/Perth/16/2009-like, the influenza A (H3N2) component of the 2010-11 influenza 
vaccine for the Northern Hemisphere. Thirty-three viruses (3.5%) of the 952 tested 
showed reduced titers with antiserum produced against A/Perth/16/2009. 
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Influenza B (B/Victoria/02/87 and B/Yamagata/16/88 lineages) [646] 
Victoria Lineage [608] 
 Six hundred eight (94.1%) of the 646 influenza B viruses tested belong to the 
B/Victoria lineage of viruses. 
o Six hundred seven (99.8%) of these 608 viruses were characterized as 
B/Brisbane/60/2008-like, the recommended influenza B component for the 
2010-11 Northern Hemisphere influenza vaccine. 
o One (0.2%) of these 608 viruses showed somewhat reduced titers with 
antisera produced against B/Brisbane/60/2008. 
Yamagata Lineage [38] 
 Thirty-eight (5.9%) of the 646 viruses were identified as belonging to the B/Yamagata 
lineage of viruses. 
Antiviral Resistance: Testing of 2009 influenza A (H1N1), influenza A (H3N2), and influenza B 
virus isolates for resistance to the neuraminidase inhibitors (oseltamivir and zanamivir) is performed 
at CDC using a functional assay. Additional 2009 influenza A (H1N1) clinical samples are tested for 
a single known mutation in the neuraminidase protein of the virus that confers oseltamivir 
resistance (H275Y). The data summarized in the table below combine the results of both test 
methods and include samples that were tested as part of routine surveillance purposes; it does not 
include diagnostic testing specifically done because of clinical suspicion of antiviral resistance. 
High levels of resistance to the adamantanes (amantadine and rimantadine) persist among 2009 
influenza A (H1N1) and A (H3N2) viruses (the adamantanes are not effective against influenza B 
viruses) circulating globally. As a result of the sustained high levels of resistance, data from 
adamantane resistance testing are not presented weekly in the table below.    
Neuraminidase Inhibitor Resistance Testing Results 
on Samples Collected Since October 1, 2010. 
 
Virus 
Samples 
tested (n) 
Resistant 
Viruses, 
Number (%) 
Virus 
Samples 
tested (n) 
Resistant 
Viruses, 
Number (%) 
Oseltamivir Zanamivir 
Seasonal 
Influenza A 
(H1N1) 
0 0 (0.0) 0 0 (0.0) 
Influenza A 
(H3N2) 
683 2 (0.3) 681 0 (0.0) 
Influenza B 607 0 (0.0) 607 0 (0.0) 
2009 
Influenza A 
(H1N1) 
2,999* 29 (1.0) 441 0 (0.0) 
*Includes specimens tested in national surveillance and additional specimens tested at public health 
laboratories in six states (CA, ME, MD, MN, TX, and WA) who share testing results with CDC. 
 
To prevent the spread of antiviral resistant virus strains, CDC reminds clinicians and the public of 
the need to continue hand and cough hygiene measures for the duration of any symptoms of 
influenza, even while taking antiviral medications. Additional information on antiviral 
recommendations for treatment and chemoprophylaxis of influenza virus infection is available at 
http://www.cdc.gov/flu/antivirals/index.htm.   
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Pneumonia and Influenza (P&I) Mortality Surveillance: During week 16, 8.0% of all deaths 
reported through the 122-Cities Mortality Reporting System were due to P&I. This percentage was 
at the epidemic threshold of 7.7% for week 16 and is the 13th consecutive week in which P&I has 
been at or above the epidemic threshold. 
 
Pneumonia and Influenza Mortality for 122 U.S. Cities 
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Influenza-Associated Pediatric Mortality: Two influenza-associated pediatric deaths were 
reported to CDC during week 16. Both of these deaths were associated with an influenza B virus. 
 
Ninety-seven influenza-associated pediatric deaths from 33 states, Chicago, and New York City 
have been reported during this influenza season. Thirty-nine of the 97 deaths reported were 
associated with influenza B viruses; 24 were associated with 2009 influenza A (H1N1) viruses; 17 
deaths reported were associated with influenza A (H3N2) viruses, and 17 were associated with an 
influenza A virus for which the subtype was not determined.   
 
Number of Influenza-Associated Pediatric Deaths by Week of Death: 
2007-08 season to present 
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Week of Death
2007-08
Number of Deaths 
Reported = 88
2008-09
Number of Deaths 
Reported = 133
2009-10
Number of Deaths 
Reported = 282
Deaths Reported Current WeekDeaths Reported Previous Week
2010-11
Number of Deaths 
Reported =  97
 
 
Influenza-Associated Hospitalizations: FluSurv-NET conducts population-based surveillance for 
laboratory-confirmed influenza-associated hospitalizations in children (persons younger than 18 
years) and adults. The current network covers more than 80 counties in the 10 Emerging Infections 
Program (EIP) states (CA, CO, CT, GA, MD, MN, NM, NY, OR, and TN) and six additional states 
(ID, MI, OH, OK, RI, and UT). 
 
The current season’s rates include cases from October 1, 2010 to April 23, 2011. 
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Please note the following: (i) The scale of the vertical axis on the Cumulative Hospitalization Rate figures will be adjusted 
during the season to make the graphs easier to read; (ii) FluSurv-NET was created during the 2009-2010 season when 
surveillance in six states was added to ongoing surveillance for influenza-associated hospitalizations in10 EIP states. 
During the 2009-2010 season, FluSurv-NET included sites in the 10 EIP sites and sites in IA, ID, MI, ND, OK, and SD; (iii) 
the 2008-2009 EIP season ended April 14, 2009, due to the onset of the 2009 H1N1 pandemic. 
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1
Asthma may include a diagnosis of asthma and reactive airway disease; Cardiovascular diseases may include conditions 
such as coronary heart disease, cardiac valve disorders, congestive heart failure, pulmonary hypertension, and aortic 
stenosis; Chronic lung diseases may include conditions such as bronchiolitis obliterans, chronic aspiration pneumonia, 
and interstitial lung disease; Immune suppression may include conditions such as immunoglobulin deficiency, leukemia, 
lymphoma, HIV/AIDS, and individuals taking immunosuppressive medications; Metabolic disorders may include conditions 
such as diabetes mellitus, thyroid dysfunction, adrenal insufficiency, and liver disease; Neurologic diseases may include 
conditions such as seizure disorders, neuromuscular disorders, and cognitive dysfunction; Obesity was defined as a body 
mass index (BMI) greater than 30 kg/m
2
 in patients 20 years of age or older, or equal to or greater than the 95
th
 percentile 
of a patient’s age and sex category in patients under 20 years of age; Renal diseases may include conditions such as 
acute or chronic renal failure, nephrotic syndrome, glomerulonephritis, and impaired creatinine clearance. 
2
Data as of April 26, 2011.  Includes 3,731 (of a total 5,917 reported) cases for which data collection has been completed 
through the medical chart review stage. 
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Demographic and clinical characteristics of laboratory-confirmed, influenza-
associated hospitalizations identified in EIP1 and FluSurv-NET2 sites, 2006-2011 
  2010-2011 
FluSurv-NET
3
 
N (%) 
2009-2010 
FluSurv-NET 
N (%) 
2008-2009 
EIP 
N (%) 
2007-2008 
EIP 
N (%) 
2006-2007 
EIP 
N (%) 
Total Cases 5,917 7,517 1,698 3,930 1,279 
Age in Years           
0-4 889 (15.0) 1,326 (17.6) 549 (32.3) 639 (16.3) 393 (30.7) 
5-17 423 (7.1) 1,204 (16.0) 244 (14.4) 221 (5.6) 130 (10.2) 
18-49 1,457 (24.6) 2,779 (37.0) 374 (22.0) 736 (18.7) 246 (19.2) 
50-64 1,137 (19.2) 1,458 (19.4) 201 (11.8) 585 (14.9) 155 (12.1) 
65+ 2,007 (33.9) 750 (10.0) 330 (19.4) 1,749 (44.5) 355 (27.8) 
Sex           
Male 2,747 (46.4) 3,517 (46.8) 832 (49.0) 1,825 (46.4) 631 (49.3) 
Female 3,164 (53.5) 4,000 (53.2) 866 (51.0) 2,104 (53.5) 648 (50.7) 
Flu Type and Subtype           
Influenza A 4,851 (82.0) 7,355 (97.8) 1,236 (72.8) 2,562 (65.2) 1,082 (84.6) 
       Specimens subtyped
4
 1,674 5,325 -- -- -- 
            A (H1) 0 (0.0) 0 (0.0) -- -- -- 
            A (H3) 1,112 (66.4) 3 (0.1) -- -- -- 
            A (2009 H1N1) 562 (33.6) 5,322 (99.9) -- -- -- 
Influenza B 955 (16.1) 52 (0.7) 382 (22.5) 1,199 (30.5) 149 (11.6) 
Intensive Care Unit 622 (16.7) 1,560 (20.8) 298 (17.6) 495 (12.6) 198 (15.5) 
Mechanical Ventilation 285 (7.6) 758 (10.1) 157 (9.2) 252 (6.4) 111 (8.7) 
Diagnosis of Pneumonia 1,056 (28.3) 2,804 (37.3) 407 (24.0) 1,220 (31.0) 404 (31.6) 
Died 89 (2.4) 222 (3.0) 49 (2.9) 104 (2.6) 24 (1.9) 
 
Columns may not sum to 100% due to missing or unknown values. 
1
Surveillance in EIP states (CA, CO, CT, GA, MD, MN, NM, NY, OR, TN) was conducted from 2006-2011. 
2
FluSurv-Net includes surveillance at EIP sites and at sites in additional states (IA, ID, MI, ND, OK, SD in 2009-2010; ID, 
MI, OH, OK, RI, UT in 2010-2011). 
3
Data as of April 26, 2011.  Results describing influenza A subtype, intensive care unit admission, mechanical ventilation, 
diagnosis of pneumonia, and death are from 3,731 (of a total 5,917 reported) cases for which data collection has been 
completed through the medical chart review stage. 
4
Influenza A subtype results are available beginning with the 2007-2008 season. Percentages for influenza A subtypes 
are calculated using the number of influenza A specimens that were subtyped as a denominator. 
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Outpatient Illness Surveillance: Nationwide during week 16, 1.3% of patient visits reported 
through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to 
influenza-like illness (ILI). This percentage is below the national baseline of 2.5%.  
 
Percentage of Visits for Influenza-like Illness (ILI) Reported by  
the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet), 
Weekly National Summary, September 30, 2007 – April 23, 2011 
0
1
2
3
4
5
6
7
8
9
%
 o
f 
V
is
it
s
 f
o
r 
IL
I 
  
 
Week
% ILI National Baseline
 
 
On a regional level, the percentage of outpatient visits for ILI ranged from 0.5% to 2.7% during 
week 16. Region 2 reported ILI above its region-specific baseline. 
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Region 6 - AR, LA, NM, OK, TX
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Region 2 - NJ, NY, USVI
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Region 3 - DE, DC, MD, PA, VA, WV
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Region 4 - AL, FL, GA, KY, MS, NC, SC, TN
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Region 5 - IL, IN, MI, MN, OH, WI
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Region 8 - CO, MT, ND, SD, UT, WY
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Region 9 - AZ, CA, HI, NV
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Region 10 - AK, ID, OR, WA
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NOTE: Scales differ between regions
*Use of the regional baselines for state data is not appropriate. 
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ILINet State Activity Indicator Map: Data collected in ILINet are used to produce a measure of ILI 
activity* by state. Activity levels are based on the percent of outpatient visits in a state due to ILI 
and are compared to the average percent of ILI visits that occur during spring and fall weeks with 
little or no influenza virus circulation. Activity levels range from minimal, which would correspond to 
ILI activity from outpatient clinics being below the average, to high, which would correspond to ILI 
activity from outpatient clinics being much higher than the average. Because the clinical definition of 
ILI is very general, not all ILI can be attributed to influenza; however, when combined with 
laboratory data, the information on ILI activity can provide a better picture of influenza activity in the 
United States. 
 
During week 16, the following ILI activity levels were experienced: 
 Minimal ILI activity was experienced by all 50 states and New York City.  
 The District of Columbia had insufficient data to calculate an activity level. 
 
Interactive web tool available at: http://gis.cdc.gov/grasp/fluview/main.html 
*This map uses the proportion of outpatient visits to health care providers for influenza-like illness to measure the ILI activity level within a state. It does not, 
however, measure the extent of geographic spread of flu within a state. Therefore, outbreaks occurring in a single city could cause the state to display high 
activity levels. 
Data collected in ILINet may disproportionately represent certain populations within a state, and therefore, may not accurately depict the full picture of 
influenza activity for the whole state. 
Data displayed in this map are based on data collected in ILINet, whereas the State and Territorial flu activity map are based on reports from state and 
territorial epidemiologists. The data presented in this map is preliminary and may change as more data is received. 
Differences in the data presented by CDC and state health departments likely represent differing levels of data completeness with data presented by the 
state likely being the more complete.  
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Geographic Spread of Influenza as Assessed by State and Territorial Epidemiologists: The 
influenza activity reported by state and territorial epidemiologists indicates geographic spread of 
influenza viruses, but does not measure the severity of influenza activity. 
 
During week 16, the following influenza activity was reported: 
 No states reported widespread influenza activity. 
 Regional influenza activity was reported by four states (Connecticut, Maine, New 
Hampshire, and New York). 
 Local influenza activity was reported by the District of Columbia and 10 states (Alabama, 
Alaska, California, Georgia, Idaho, Massachusetts, Minnesota, Montana, Ohio, and 
Vermont). 
 Sporadic influenza activity was reported by Puerto Rico and 32 states (Arizona, Arkansas, 
Colorado, Florida, Hawaii, Illinois, Indiana, Iowa, Kansas, Louisiana, Maryland, Michigan, 
Mississippi, Missouri, Nebraska, Nevada, New Jersey, New Mexico, North Carolina, North 
Dakota, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, 
Texas, Utah, Virginia, Washington, Wisconsin, and Wyoming). 
 The U.S. Virgin Islands, Guam, and four states (Delaware, Kentucky, Rhode Island, and 
West Virginia) reported no influenza activity. 
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Additional National and International Influenza Surveillance Information 
 
Distribute Project: Additional information on the Distribute syndromic surveillance project, 
developed and piloted by the International Society for Disease Surveillance (ISDS), now working in 
collaboration with CDC to enhance and support Emergency Department (ED) surveillance, is 
available at http://isdsdistribute.org/. 
 
Google Flu Trends: Google Flu Trends uses aggregated Google search data in a model created in 
collaboration with CDC to estimate influenza activity in the United States. For more information and 
activity estimates from the U.S. and worldwide, see http://www.google.org/flutrends/. 
 
Europe: For the most recent influenza surveillance information from Europe, please see 
WHO/Europe at http://www.euroflu.org/index.php and visit the European Centre for Disease 
Prevention and Control at 
http://ecdc.europa.eu/en/publications/surveillance_reports/influenza/Pages/weekly_influenza_survei
llance_overview.aspx. 
 
Public Health Agency of Canada: The most up-to-date influenza information from Canada is 
available at http://www.phac-aspc.gc.ca/fluwatch/. 
 
World Health Organization FluNet: Additional influenza surveillance information from participating 
WHO member nations is available at http://gamapserver.who.int/GlobalAtlas/home.asp. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A description of surveillance methods is available at: http://www.cdc.gov/flu/weekly/overview.htm 
Report prepared: April 29, 2011. 
  
